Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma

Creative Commons License

Gulec Ü., Bagir E. K., PAYDAŞ S., GÜZEL A. B., GÜMÜRDÜLÜ D., VARDAR M. A.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.244, ss.51-55, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 244
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.ejogrb.2019.11.006
  • Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.51-55
  • Anahtar Kelimeler: Carcinosarcoma, Programmed death-1 (PD-1), Programmed death-ligand 1 (PD-L1), Prognosis, Uterine, CANCER, CHEMOTHERAPY, MANAGEMENT, BLOCKADE, IMPACT, TUMORS, CELLS
  • Çukurova Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study was to evaluate the clinical and prognostic importance of programmed death-1 (PD-1) and/ or programmed death-ligand 1 (PD-L1) in uterine carcinosarcoma (UCS).